|
89
|
266
|
6h2aA |
Structure of s70a blac from mycobacterium tuberculosis obtained from crystals produced in the presence of dtt |
|
90
|
271
|
6h28A |
Structure of s70a blac from mycobacterium tuberculosis obtained from crystals produced in the absence of dtt |
|
90
|
269
|
6h27A |
Structure of s70c blac from mycobacterium tuberculosis |
|
119
|
359
|
6g9tA |
Crystal structure of cmy-136 class c beta-lactamase |
|
98
|
270
|
6dmhA |
A multiconformer ligand model of acylenzyme intermediate of meropenem bound to an sfc-1 e166a mutant |
|
81
|
239
|
5o2eA |
Crystal structure of ndm-1 in complex with hydrolyzed cefuroxime - new refinement |
|
90
|
260
|
5zb7A |
Ctx-m-64 apoenzyme |
|
77
|
243
|
5o2fA |
Crystal structure of ndm-1 in complex with hydrolyzed ampicillin - new refinement |
|
83
|
242
|
6q5fA |
Oxa-48_p68a-caz. evolutionary trade-offs of oxa-48 mediated ceftazidime-avibactam resistance |
|
85
|
242
|
6q5fB |
Oxa-48_p68a-caz. evolutionary trade-offs of oxa-48 mediated ceftazidime-avibactam resistance |
|
78
|
229
|
6q30A |
Crystal structure of ndm-1 beta-lactamase in complex with boronic inhibitor cpd 5 |
|
85
|
242
|
6q5bA |
Oxa-48_p68a-avi. evolutionary trade-offs of oxa-48 mediated ceftazidime-avibactam resistance |
|
86
|
242
|
6q5bB |
Oxa-48_p68a-avi. evolutionary trade-offs of oxa-48 mediated ceftazidime-avibactam resistance |
|
78
|
229
|
6d1gA |
Crystal structure of ndm-1 complexed with compound 9 |
|
100
|
267
|
6q35A |
Crystal structure of ges-5 beta-lactamase in complex with boronic inhibitor cpd 3 |
|
86
|
266
|
6mnpA |
Crystal structure of kpc-2 with compound 6 |
|
94
|
262
|
6miaA |
Crystal structure of ctx-m-14 with compound 6 |
|
98
|
267
|
6m7iA |
Crystal structure of kpc-2 with compound 3 |
|
94
|
264
|
6meyA |
Crystal structure of kpc-2 with compound 9 |
|
91
|
268
|
6mllA |
Crystal structure of kpc-2 with compound 7 |
|
77
|
229
|
6mduA |
Crystal structure of ndm-1 with compound 7 |
|
80
|
229
|
6d1dA |
Crystal structure of ndm-1 complexed with compound 6 |
|
93
|
270
|
6d16A |
Crystal structure of kpc-2 complexed with compound 2 |
|
96
|
270
|
6d15A |
Crystal structure of kpc-2 complexed with compound 1 |
|
79
|
229
|
6d1eA |
Crystal structure of ndm-1 complexed with compound 7 |
|
75
|
229
|
6efjA |
Crystal structure of ndm-1 with compound 9 |
|
77
|
229
|
6d1jA |
Crystal structure of ndm-1 complexed with compound 13 |
|
74
|
229
|
6ibsA |
Crystal structure of ndm-1 beta-lactamase in complex with boronic inhibitor cpd 6 |
|
76
|
229
|
6d1bA |
Crystal structure of ndm-1 complexed with compound 2 |
|
73
|
231
|
6ibvA |
Crystal structure of ndm-1 beta-lactamase in complex with broad spectrum boronic inhibitor cpd 1 |
|
78
|
229
|
6d1fA |
Crystal structure of ndm-1 complexed with compound 8 |
|
77
|
229
|
6d1aA |
Crystal structure of ndm-1 complexed with compound 1 |
|
77
|
229
|
6d1kA |
Crystal structure of ndm-1 complexed with compound 14 |
|
96
|
270
|
6d18A |
Crystal structure of kpc-2 complexed with compound 6 |
|
76
|
229
|
6d1cA |
Crystal structure of ndm-1 complexed with compound 3 |
|
78
|
229
|
6d1iA |
Crystal structure of ndm-1 complexed with compound 12 |
|
94
|
279
|
6d3gA |
Per-2 class a extended-spectrum beta-lactamase crystal structure in complex with avibactam at 2.4 angstrom resolution |
|
93
|
270
|
6d17A |
Crystal structure of kpc-2 complexed with compound 3 |
|
96
|
269
|
6d19A |
Crystal structure of kpc-2 complexed with compound 9 |
|
76
|
229
|
6d1hA |
Crystal structure of ndm-1 complexed with compound 11 |
|
91
|
260
|
5zflA |
Crystal structure of beta-lactamase penp mutant e166y |
|
77
|
229
|
5zj7A |
Crystal structure of ndm-1 in complex with d-captopril derivative cy22 |
|
77
|
228
|
5zjcA |
Crystal structure of ndm-1 in complex with d-captopril derivative cy41 |
|
78
|
229
|
5zj1A |
Crystal structure of ndm-1 in complex with d-captopril derivative cyt-14 |
|
78
|
228
|
5zioA |
Crystal structure of ndm-1 in complex with l-captopril |
|
77
|
229
|
5zj8A |
Crystal structure of ndm-1 in complex with d-captopril derivative cy32 |
|
90
|
256
|
5zg6A |
Crystal structure of beta-lactamase penp mutant-e166y in complex with cephaloridine as "post-acylation" intermediate |
|
76
|
229
|
5zj2A |
Crystal structure of ndm-1 in complex with d-captopril |
|
93
|
258
|
5zftA |
Crystal structure of beta-lactamase penp mutant-e166y in complex with cephaloridine as "pre-deacylation" intermediate |
|
63
|
205
|
3sw3A |
Edta-free crystal structure of the mutant c221d of carbapenemase cpha from aeromonas hydrophila |
